PA SB1022

Requires health care professionals to coprescribe an emergency opioid antagonist (such as naloxone) whenever issuing an initial or renewal opioid prescription in Pennsylvania

Mandates public schools and public institutions of higher education to maintain emergency opioid antagonist supplies, designate trained employees to store and administer them, and provide overdose response training to staff and students

Requires correctional institutions to train staff and incarcerated individuals on opioid overdose response, maintain emergency opioid antagonist supplies, and offer naloxone along with usage instructions to individuals upon release from incarceration

Directs the Department of Health, in consultation with the Department of Drug and Alcohol Programs, to develop and publish free model training programs covering overdose recognition, naloxone administration, and relevant liability protections tailored to various groups including schools, correctional staff, first responders, and laypeople

Takes effect 60 days after enactment and allows parents or guardians of minor students to opt out of having their children receive emergency opioid antagonists at school